News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
804,040 Results
Type
Article (58940)
Company Profile (374)
Press Release (744710)
Multimedia
Podcasts (177)
Webinars (27)
Section
Business (220218)
Career Advice (2979)
Deals (37892)
Drug Delivery (168)
Drug Development (87139)
Employer Resources (188)
FDA (17792)
Job Trends (16271)
News (373795)
Policy (36288)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (3002)
Academic (1)
Accelerated approval (56)
ADA (49)
Adcomms (39)
Allergies (206)
Alliances (54359)
ALS (240)
Alzheimer's disease (1959)
Antibody-drug conjugate (ADC) (560)
Approvals (18175)
Artificial intelligence (817)
ASCO (345)
Autoimmune disease (358)
Automation (67)
Bankruptcy (394)
Best Places to Work (12306)
BIO (71)
BIOSECURE Act (21)
Biosimilars (245)
Biotechnology (240)
Bladder cancer (213)
Brain cancer (84)
Breast cancer (839)
Cancer (6597)
Cardiovascular disease (547)
Career advice (2536)
Career pathing (50)
CAR-T (383)
CDC (72)
Celiac Disease (3)
Cell therapy (1041)
Cervical cancer (58)
Clinical research (75649)
Collaboration (2370)
Commercialization (1)
Company closure (7)
Compensation (1520)
Complete response letters (101)
COVID-19 (3001)
CRISPR (126)
C-suite (1311)
Cystic fibrosis (165)
Data (8807)
Decentralized trials (3)
Denatured (60)
Depression (194)
Dermatology (98)
Diabetes (700)
Diagnostics (7507)
Digital health (66)
Diversity (14)
Diversity, equity & inclusion (46)
Drug discovery (399)
Drug pricing (235)
Drug shortages (36)
Duchenne muscular dystrophy (325)
Earnings (95619)
Editorial (78)
Employer branding (24)
Employer resources (167)
Events (130235)
Executive appointments (1201)
FDA (21901)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (35)
Funding (1957)
Gene editing (272)
Generative AI (72)
Gene therapy (826)
GLP-1 (1232)
Government (5315)
Grass and pollen (8)
Guidances (422)
Healthcare (20701)
Hematology (196)
HIV (97)
Huntington's disease (64)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (114)
Immunology and inflammation (345)
Immuno-oncology (113)
Indications (218)
Infectious disease (3400)
Inflammatory bowel disease (241)
Inflation Reduction Act (15)
Influenza (151)
Intellectual property (326)
Interviews (583)
IPO (17338)
IRA (58)
Job creations (4278)
Job search strategy (2051)
JPM (70)
Kidney cancer (22)
Labor market (112)
Layoffs (654)
Leadership (52)
Legal (8990)
Liver cancer (111)
Longevity (37)
Lung cancer (874)
Lymphoma (481)
Machine learning (68)
Management (66)
Manufacturing (1209)
Marketing (3)
MASH (228)
Medical affairs (1)
Medical device (14998)
Medtech (15174)
Mergers & acquisitions (21868)
Metabolic disorders (1787)
mRNA (268)
Multiple sclerosis (209)
NASH (24)
Neurodegenerative disease (506)
Neuropsychiatric disorders (127)
Neuroscience (3708)
Neurotech (1)
NextGen: Class of 2026 (7270)
Non-profit (5001)
Now hiring (82)
Obesity (837)
Opinion (360)
Ovarian cancer (244)
Pain (283)
Pancreatic cancer (366)
Parkinson's disease (415)
Partnered (36)
Patents (659)
Patient recruitment (788)
Peanut (71)
People (65472)
Pharmaceutical (72)
Pharmacy benefit managers (36)
Phase 1 (23579)
Phase 2 (33178)
Phase 3 (24735)
Pipeline (10011)
Policy (387)
Postmarket research (2942)
Preclinical (10207)
Press Release (72)
Prostate cancer (347)
Psychedelics (72)
Radiopharmaceuticals (372)
Rare diseases (1271)
Real estate (6729)
Recruiting (77)
Regulatory (28131)
Reports (57)
Research institute (2708)
Resumes & cover letters (470)
Rett syndrome (45)
RNA editing (30)
RSV (97)
Schizophrenia (196)
Series A (337)
Series B (246)
Service/supplier (15)
Sickle cell disease (129)
Special edition (29)
Spinal muscular atrophy (183)
Sponsored (53)
Startups (4060)
State (2)
Stomach cancer (21)
Supply chain (143)
Tariffs (98)
The Weekly (114)
Vaccines (1277)
Venture capital (138)
Weight loss (557)
Women's health (141)
Worklife (24)
Date
Last 7 days (464)
Last 30 days (2390)
Last 365 days (31797)
2026 (16750)
2025 (31844)
2024 (37054)
2023 (42005)
2022 (53279)
2021 (57976)
2020 (56886)
2019 (50231)
2018 (38055)
2017 (35007)
2016 (35081)
2015 (41254)
2014 (35303)
2013 (30765)
2012 (32884)
2011 (33297)
2010 (31525)
Location
Africa (974)
Alabama (96)
Alaska (7)
Arizona (390)
Arkansas (16)
Asia (46073)
Australia (8264)
California (14342)
Canada (4014)
China (1581)
Colorado (611)
Connecticut (631)
Delaware (448)
Europe (103508)
Florida (2136)
Georgia (469)
Hawaii (3)
Idaho (68)
Illinois (1213)
India (99)
Indiana (651)
Iowa (25)
Japan (610)
Kansas (141)
Kentucky (55)
Louisiana (61)
Maine (76)
Maryland (1715)
Massachusetts (10425)
Michigan (416)
Minnesota (794)
Mississippi (7)
Missouri (161)
Montana (37)
Nebraska (30)
Nevada (153)
New Hampshire (91)
New Jersey (3774)
New Mexico (34)
New York (3777)
North Carolina (1893)
North Dakota (11)
Northern California (7206)
Ohio (442)
Oklahoma (25)
Oregon (47)
Pennsylvania (2836)
Puerto Rico (33)
Rhode Island (54)
South America (1360)
South Carolina (88)
South Dakota (2)
Southern California (5677)
Tennessee (233)
Texas (2329)
United States (51046)
Utah (428)
Vermont (2)
Virginia (358)
Washington D.C. (87)
Washington State (1168)
West Virginia (4)
Wisconsin (148)
Wyoming (2)
804,040 Results for "starkey hearing technologies formerly known as starkey laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Diazyme Laboratories, Inc. Announces FDA 510(k) Clearance for Lipoprotein(a) Molarity Assay
June 19, 2026
·
1 min read
Gene therapy
FDA approval of Regeneron’s hearing loss gene therapy breaks barriers
Approved Thursday via the FDA’s Commissioner’s National Priority Voucher program, Otarmeni is the first gene therapy for hearing loss—and the first treatment to target an underlying cause of the condition.
April 23, 2026
·
4 min read
·
Heather McKenzie
Press Releases
Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology
Australian and European Patent Offices Grant the Company Four Patents Relating to Key Innovations in Implantable System Design, Signal Analysis, and Battery Recharge Safety
May 20, 2026
·
8 min read
Press Releases
Otarmeni™ (lunsotogene parvec) Receives EMA Filing Acceptance for Genetic Hearing Loss
May 22, 2026
·
11 min read
Press Releases
OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections
June 11, 2026
·
5 min read
Press Releases
Mighty Therapeutics, Formerly Stealth BioTherapeutics, Announces New Name Honoring the Mitochondrial Disease Community
June 16, 2026
·
6 min read
Press Releases
Sensorion Achieves Key Regulatory Milestones for SENS-601 for GJB2-related Hearing Loss and Selects Program as Lead Gene Therapy Candidate
June 10, 2026
·
9 min read
Gene editing
Lilly Leans Into Hearing Loss in $1.12B+ Gene Editing Pact With Seamless
The deal will help bolster Eli Lilly’s growing hearing loss portfolio, which is anchored by the gene therapy AK-OTOF.
January 28, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Skylark Bio to Present New Preclinical Data for its Pendrin Gene Therapy Program for Hearing Loss at ASGCT 2026
May 13, 2026
·
3 min read
Press Releases
Envoy Medical Secures Four New Global Patents, Expanding Its Leadership Position in Fully Implantable Hearing Technology
Patents strengthen Envoy Medical’s innovation pipeline and protect next-generation cochlear implant solutions for individuals living with hearing loss.
September 10, 2025
·
8 min read
1 of 80,404
Next
